No photo of Daniel R Ganger

View Scopus Profile

Daniel R Ganger

  • 2684 Citations
1980 …2021
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

Management of patients with Chronic Liver Disease, pre and post liver transplant.

Received Medical Degree a the University of Buenos Aires. Internal Medicine training at St Louis University Missouri and Gastroenterology /Hepatology at Northwestern University. Academic Title: Professor of Medicine and Surgery Feinberg School of Medicine.

Assessment of liver disease in patients with congenital heart disease. Research protocols. Acute Liver Failure Management. NIH grant through the Acute Liver Failure Study Group.

Certifications and Licenses

Transplant Hepatology
Internal Medicine
Gastroenterology

Training Experience

1978Internship, Rambam Medical Center, Israel
1981Residency, Rambam Medical Center, Israel
1984Fellowship, Saint Louis University School of Medicine
1984Residency, St. Louis University Hospital
1986Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital)

Education/Academic qualification

MD, University of Buenos Aires

… → 1976

Research interests

  • Congenital Heart Disease
  • Liver Disease / Pathobiology
  • Transplantation
  • Viral Hepatitis

Fingerprint Dive into the research topics where Daniel R Ganger is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 22 Similar Profiles
Acute Liver Failure Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences
Liver Medicine & Life Sciences
Transjugular Intrahepatic Portasystemic Shunt Medicine & Life Sciences
Portal Vein Medicine & Life Sciences
Survival Medicine & Life Sciences
Liver Transplantation Medicine & Life Sciences
Acetaminophen Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2005 2021

HepQuant to predict hepatic encephalopathy in patients who receive transjugular intrahepatic portosystemic shunt (TIPS) for refractory ascites – a pilot study

Ganger, D. R.

Northwestern Memorial Hospital, Digestive Health Foundation

7/1/19 → 6/30/20

Project: Research project

Prot# M16-135: A Single Arm, Open-label Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment Naïve Adults with Chronic Hepatitis C Virus (HCV) Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis

Flamm, S. L. & Ganger, D. R.

AbbVie Inc.

9/8/17 → 9/7/20

Project: Research project

Prot# MNK19013058: A Multi-Center, Randomized, Placebo-Controlled, Double-Blind Study to Confirm Efficacy and Safety of Terlipressin in Subjects with Hepatorenal Syndrome Type 1

Ganger, D. R.

International HealthCare, LLC, Mallinckrodt Hospital Products Inc.

6/15/16 → 6/15/21

Project: Research project

Acute Liver Failure Study Group 13C-Methacetin Breath Test for the Prediction of Outcome in Acute Liver Failure

Ganger, D. R.

University of Texas Southwestern Medical Center at Dallas, National Institute of Diabetes, Digestive and Kidney Diseases

2/19/16 → 8/31/20

Project: Research project

Breath Tests
Acute Liver Failure
Time Management
Registries
Clinical Trials

A Multi-Center Group to Study Acute Liver Failure

Ganger, D. R.

University of Texas Southwestern Medical Center at Dallas, National Institute of Diabetes, Digestive and Kidney Diseases

9/16/15 → 8/31/20

Project: Research project

Acute Liver Failure
Hematologic Diseases
Liver
Sepsis
Viruses

Research Output 1980 2019

  • 2684 Citations
  • 75 Article
  • 6 Review article
  • 4 Letter
  • 1 Comment/debate

Assessing hepatic impairment in Fontan-associated liver disease using the HepQuant SHUNT test

Lemmer, A., VanWagner, L. B., Gasanova, Z., Helmke, S., Everson, G. T. & Ganger, D. R., Jan 1 2019, In : Congenital Heart Disease.

Research output: Contribution to journal › Article

Liver Diseases
Liver
Cholates
Fontan Procedure
Deuterium
2 Citations (Scopus)

Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study

Lai, J. C., Rahimi, R. S., Verna, E. C., Kappus, M. R., Dunn, M. A., McAdams-DeMarco, M., Haugen, C. E., Volk, M. L., Duarte-Rojo, A., Ganger, D. R., O'Leary, J. G., Dodge, J. L., Ladner, D. P. & Segev, D. L., May 1 2019, In : Gastroenterology. 156, 6, p. 1675-1682 8 p.

Research output: Contribution to journal › Article

Hepatic Encephalopathy
Ascites
Multicenter Studies
Mortality
Confidence Intervals

Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and Validation

Ali, R., Yang, Y., Antkowiak, M., Gabr, A., Mora, R., Abouchaleh, N., Al Asadi, A., Kulik, L. M., Ganger, D. R., Abecassis, M. M., Kataraya, N., Mulcahy, M. F., Benson III, A. B., Mahalingam, D., Thornburg, B., Mouli, S. K., Lewandowski, R. J., Salem, R. & Riaz, A., Jan 1 2019, In : Cardiovascular and Interventional Radiology.

Research output: Contribution to journal › Article

alpha-Fetoproteins
Hepatocellular Carcinoma
Survival
Research Ethics Committees
ROC Curve

Prognostic role of albumin, bilirubin, and ALBI scores: Analysis of 1000 patients with hepatocellular carcinoma undergoing radioembolization

Antkowiak, M., Gabr, A., Das, A., Ali, R., Kulik, L. M., Ganger, D. R., Moore, C. M., Abecassis, M. M., Katariya, N. N., Mouli, S. K., Mahalingam, D., Lewandowski, R. J., Salem, R. & Riaz, A., Jun 1 2019, In : Cancers. 11, 6, 879.

Research output: Contribution to journal › Article

Open Access
Bilirubin
Albumins
Hepatocellular Carcinoma
Survival
Yttrium
5 Citations (Scopus)

Acute Liver Failure of Indeterminate Etiology: A Comprehensive Systematic Approach by An Expert Committee to Establish Causality

for the Acute Liver Failure Study Group, Sep 1 2018, In : American Journal of Gastroenterology. 113, 9, p. 1319-1328 10 p.

Research output: Contribution to journal › Article

Acute Liver Failure
Acetaminophen
Causality
Chemical and Drug Induced Liver Injury
Metagenomics